We've found
7,522
archived clinical trials in
Chronic Pain
We've found
7,522
archived clinical trials in
Chronic Pain
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
Updated: 12/8/2017
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies
Updated: 12/13/2017
An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
Updated: 12/15/2017
Supervised Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
Status: Enrolling
Updated: 12/15/2017
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
Updated: 12/15/2017
Supervised Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
Status: Enrolling
Updated: 12/15/2017
Click here to add this to my saved trials
Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study
Updated: 12/21/2017
Ketamine Effect on Recovery and Respiratory Outcomes After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study
Status: Enrolling
Updated: 12/21/2017
Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study
Updated: 12/21/2017
Ketamine Effect on Recovery and Respiratory Outcomes After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study
Status: Enrolling
Updated: 12/21/2017
Click here to add this to my saved trials
MS Symptom Management Study
Updated: 12/21/2017
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated: 12/21/2017
MS Symptom Management Study
Updated: 12/21/2017
Enhancing the Benefits of Pain and Fatigue Treatment in MS
Status: Enrolling
Updated: 12/21/2017
Click here to add this to my saved trials
Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Updated: 12/21/2017
A Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Status: Enrolling
Updated: 12/21/2017
Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Updated: 12/21/2017
A Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Status: Enrolling
Updated: 12/21/2017
Click here to add this to my saved trials
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
Updated: 12/26/2017
A Phase 1b, Double-Blind, Randomized, Placebo-Controlled, Three Segment Cross-Over Study Investigating Oral Steady-State Pharmacokinetics And Hypoalgesic Effect Of 20 Mg Omnitram And 50 Mg Tramadol In Normal Human Subjects Made Cyp2d6 Deficient By Paroxetine
Status: Enrolling
Updated: 12/26/2017
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
Updated: 12/26/2017
A Phase 1b, Double-Blind, Randomized, Placebo-Controlled, Three Segment Cross-Over Study Investigating Oral Steady-State Pharmacokinetics And Hypoalgesic Effect Of 20 Mg Omnitram And 50 Mg Tramadol In Normal Human Subjects Made Cyp2d6 Deficient By Paroxetine
Status: Enrolling
Updated: 12/26/2017
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Updated: 1/1/2018
Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Status: Enrolling
Updated: 1/1/2018
Click here to add this to my saved trials
Effects of tDCS and tUS on Pain Perception in OA of the Knee
Updated: 1/4/2018
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Osteoarthritis of the Knee.
Status: Enrolling
Updated: 1/4/2018
Effects of tDCS and tUS on Pain Perception in OA of the Knee
Updated: 1/4/2018
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Osteoarthritis of the Knee.
Status: Enrolling
Updated: 1/4/2018
Click here to add this to my saved trials
A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement
Updated: 1/4/2018
A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement
Status: Enrolling
Updated: 1/4/2018
A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement
Updated: 1/4/2018
A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement
Status: Enrolling
Updated: 1/4/2018
Click here to add this to my saved trials
Intrathecal Hydromorphone for Pain Control After Cesarean Section
Updated: 1/5/2018
Comparison of Intrathecal Hydromorphone and Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery
Status: Enrolling
Updated: 1/5/2018
Intrathecal Hydromorphone for Pain Control After Cesarean Section
Updated: 1/5/2018
Comparison of Intrathecal Hydromorphone and Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery
Status: Enrolling
Updated: 1/5/2018
Click here to add this to my saved trials
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Updated: 1/8/2018
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated: 1/8/2018
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Updated: 1/8/2018
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials